Skip to content


Volume 9 Supplement 2

AIDS Vaccine 2012

  • Oral presentation
  • Open Access

New tools to measure community and stakeholder engagement and its impact on outcomes of clinical research

  • 1,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 5,
  • 7 and
  • 8
Retrovirology20129 (Suppl 2) :O24

  • Published:


  • Clinical Research
  • Effective Strategy
  • Final Version
  • Research Setting
  • Research Site


Community and stakeholder engagement have increasingly been acknowledged as best practice in the design and implementation of global clinical research, results dissemination and strategies for access to new health products. Existing guidelines and best practices, however, provide little insight into the expected outcomes of engagement activities, indicators of success, or useful monitoring and evaluation (M&E) tools for assessing impact on research and communities.


To fill this gap, a consortium of organizations (AVAC, HANC, International HIV/AIDS Alliance, IAVI, NIAID, TB Alliance and Wellcome Trust), developed and field tested a user-friendly M&E Toolkit for engagement programs in clinical research settings in developing countries. From a broad review across clinical trial settings, the toolkit builds on existing practices and introduces new methods for M&E, indicators for impact and guidelines for effective use. The toolkit was piloted with TB and/or HIV research sites in Africa and Asia that have a history of incorporating engagement strategies in research.


New indicators for measuring the degree of engagement and its impact on clinical research were identified. Participants in pilot-testing utilized existing and new methods of evaluation, and assessed the relationship of these strategies on targeted outcomes of clinical research. Feedback and lessons learned are being incorporated into a final version of the M&E Toolkit.


Understanding the impact of stakeholder engagement on clinical research is critical for the development and implementation of effective strategies, and for planning and optimizing clinical trials and their outcomes in developing countries. Through the use of the toolkit site and sponsor staff can better evaluate strategies and activities, demonstrate benefit, reallocate resources to activities that were most productive, and make the case for engaging stakeholders in research.

Authors’ Affiliations

International AIDS Vaccine Initiative, Nairobi, Kenya
AVAC, New York, NY, USA
Global Alliance for TB Drug Development, New York, NY, USA
Wellcome Trust, London, UK
National Institute of Allergy and Infectious Diseases, USA
Fred Hutchinson Cancer Research Center, USA
International HIV/AIDS Alliance, UK
Concept Systems, Ithaca, NY, USA


© Bahati et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.